Yeah all looking ok but they now have to do a private placement for the shortfall for the rights issue as it was not underwritten. Don't know what price they will get?
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025